VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
NCT00467441
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Excessive Somnolence
Interventions
DRUG:
VSF-173
Sponsor
Vanda Pharmaceuticals